Skip to main content
. 2014 Sep 5;55(9):608–614. doi: 10.4111/kju.2014.55.9.608

TABLE 1.

All clinicopathogic factors were not different between two groups except OABSS

graphic file with name kju-55-608-i001.jpg

Values are presented as mean±standard deviation.

OABSS, overactive bladder symptom score; BMI, body mass index; PSA, prostate-specific antigen; TRUS, transrectal ultrasound; Qmax, maximum flow rate; R/U, residual urine; IIEF5, International Index of Erectile Function-5; IPSS, International Prostate Symptom Score; QoL, quality of life.

Group A: tamsulosin 0.2 mg only. Group B: tamsulosin 0.2 mg+solifenacin 5 mg.